Danish pharma giant Novo Nordisk teased promising early-stage demo results of its experimental weight loss pill amycretin, sending the corporate’s stock surging.GLP-one agonist medication, generally identified as GLP-1s, are injectable prescription drugs that work by mimicking the GLP-one hormone that your little intestine tends to make in reacti… Read More